# NextCure, Inc. (NXTC) — merger/definitive [pending]
Source: SEC API (secapi.ai) · situation sit_cde0987ccd5c0ef809d5 · retrieved 2026-08-11T15:50:47.396Z

## Overview
NextCure, Inc. is acquiring Avere Therapeutics, Inc., which is developing AVR-001, a potentially best-in-class once-weekly oral peptide IL-23 receptor antagonist (IL-23RA) for the treatment of psoriasis, inflammatory bowel disease, and psoriatic arthritis.

NextCure, Inc. has entered into an Agreement and Plan of Merger and Reorganization dated July 14, 2026, with Avere Therapeutics, Inc. Under the transaction structure, NextCure's wholly owned subsidiary Neptune Merger Sub Corp. will merge with and into Avere, with Avere continuing as a wholly owned subsidiary of NextCure. Immediately following, Avere will merge with and into NextCure's second subsidiary Neptune Second Merger Sub, LLC, with the latter continuing as a wholly owned subsidiary of NextCure. The filing does not disclose the transaction value, consideration type, or expected closing date.

## Terms
- Counterparty: Avere Therapeutics, Inc.

## Key dates
- Announced 2026-08-04

## Timeline
- 2026-08-04 · 425 (0001104659-26-090069): 425 - NextCure, Inc. — *NextCure, Inc. is acquiring Avere Therapeutics, Inc., which is developing AVR-001, a potentially best-in-class once-weekly oral peptide IL-23 receptor antagonist (IL-23RA) for the treatment of psoriasis, inflammatory bowel disease, and psoriatic arthritis.* NextCure, Inc. has entered into an Agreement and Plan of Merger and Reorganization dated July 14, 2026, with Avere Therapeutics, Inc. Under the transaction structure, NextCure's wholly owned subsidiary Neptune Merger Sub Corp. will merge with and into Avere, with Avere continuing as a wholly owned subsidiary of NextCure. Immediately following, Avere will merge with and into NextCure's second subsidiary Neptune Second Merger Sub, LLC, with the latter continuing as a wholly owned subsidiary of NextCure. The filing does not disclose the transaction value, consideration type, or expected closing date.
  https://www.sec.gov/Archives/edgar/data/1661059/0001104659-26-090069.txt

## Citations
- 0001104659-26-090069 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926090069